Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE / Ang II / AGTR1 signaling pathway

Fig. 3

The effects of celastrol on diabetes-induced. (A) Representative M-mode and Doppler echocardiography images. (B-E) Relative quantification of cardiac function parameters of mice, including left ventricular end-systolic diameter and end-diastolic diameter (LVESD, LVEDD), ejection fraction (EF), and early mitral diastolic wave/late mitral diastolic wave (E/A) ratio. Data are shown as mean ± SD. n = 6, *P < 0.05 vs. Control; # P < 0.05 vs. DCM + celastrol.

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us